Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 5.94B | 5.74B | 5.42B | 4.98B | 4.80B |
Gross Profit | 1.50B | 1.54B | 1.41B | 1.39B | 1.37B |
EBITDA | 179.89M | 563.97M | 447.87M | 389.12M | 419.48M |
Net Income | -109.79M | 248.58M | 26.29M | 130.26M | 163.80M |
Balance Sheet | |||||
Total Assets | 6.88B | 7.75B | 7.27B | 7.75B | 7.51B |
Cash, Cash Equivalents and Short-Term Investments | 2.76B | 3.15B | 2.81B | 3.46B | 3.38B |
Total Debt | 227.05M | 288.00M | 122.55M | 135.19M | 39.82M |
Total Liabilities | 2.00B | 2.66B | 2.42B | 2.21B | 2.03B |
Stockholders Equity | 4.88B | 5.09B | 4.85B | 5.55B | 5.47B |
Cash Flow | |||||
Free Cash Flow | -223.41M | 416.95M | 89.69M | 145.76M | -197.28M |
Operating Cash Flow | -148.54M | 633.87M | 318.98M | 328.34M | 148.48M |
Investing Cash Flow | -82.62M | -213.83M | -225.74M | -177.84M | -344.70M |
Financing Cash Flow | -157.21M | -79.13M | -746.24M | -67.54M | -85.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥9.59B | 6.90 | 1.85% | 7.69% | 37.20% | ||
78 Outperform | ¥50.22B | 7.70 | 3.27% | 3.82% | 22.43% | ||
77 Outperform | ¥10.37B | 9.93 | 2.96% | 6.92% | -11.70% | ||
72 Outperform | ¥19.63B | 11.34 | 4.17% | 4.95% | 6.57% | ||
66 Neutral | ¥2.24B | 5.38 | 2.46% | 3.41% | 44.36% | ||
63 Neutral | ¥2.82B | 14.08 | 6.18% | 3.53% | -144.16% | ||
63 Neutral | $17.10B | 10.62 | -8.48% | 2.94% | 1.62% | -25.72% |